In addition, combining GLP-1R agonists with other peptide agonists or small-molecule therapeutics, including fibroblast growth factor 21 (FGF21), the farnesoid X receptor (FXR) agonist cilofexor with/without the acetyl coenzyme A carboxylase inhibitor firsocostat, a long-acting amylin agonist, cannabinoid receptor antagonists and sodium-glucose cotransporter 2 inhibitors (SGLT-2i), is currently being explored and may lead to additional improvements in NASH features vs GLP-1R agonists therapy alone [79,80,81,82,83]
Understanding what happens when you stop can help you make informed decisions with your healthcare provider
NuMedica Salicin-B IC combines white willow bark, curcumin, boswellia, and botanicals for mobility, connective tissue, and wellness-focused routines
Kosuge 2006
Persister cancer cells: Iron addiction and vulnerability to ferroptosis